The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMPALA, a randomized phase III study in patients with metastatic colorectal carcinoma: Immunomodulatory maintenance therapy with TLR-9 agonist MGN1703.
 
David Cunningham
No Relationships to Disclose
 
Alfredo Zurlo
Leadership - MOLOGEN
 
Ramon Salazar
No Relationships to Disclose
 
Michel Ducreux
No Relationships to Disclose
 
Tom Samuel Waddell
No Relationships to Disclose
 
Alexander Stein
No Relationships to Disclose
 
Christophe Tournigand
No Relationships to Disclose
 
Werner Scheithauer
No Relationships to Disclose
 
Alberto F. Sobrero
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Dirk Arnold
No Relationships to Disclose